Multiple sclerosis is still regarded primarily as a disease of the white matter. However, recent
evidence suggests that there may be significant involvement of gray matter. Here, we have …

In patients presenting with a clinically isolated syndrome, MRI can support and substitute
clinical information in the diagnosis of multiple sclerosis by showing disease dissemination in …

Over the past few years, new-generation cell-based assays have demonstrated a robust
association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-…

See de Seze (doi: 10.1093/brain/awx292 ) for a scientific commentary on this article. A condition
associated with an autoantibody against MOG has been recently recognized as a new …

MRI red flags proposed over a decade ago by the European Magnetic Resonance Network
in MS (MAGNIMS) have guided clinicians in the diagnosis of multiple sclerosis (MS). …

Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …

The 2015 Magnetic Resonance Imaging in Multiple Sclerosis and 2016 Consortium of Multiple
Sclerosis Centres guidelines on the use of MRI in diagnosis and monitoring of multiple …

Since its initial reports in the 19th century, neuromyelitis optica (NMO) had been thought to
involve only the optic nerves and spinal cord. However, the discovery of highly specific anti–…

Objective: To develop formal consensus-based guidance for the management of myasthenia
gravis (MG). Methods: In October 2013, the Myasthenia Gravis Foundation of America …

Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS demyelination…